
至 2030 年亚太地区分子诊断市场预测 – 区域分析 – 按疾病领域(肿瘤、传染病、基因检测、心脏病、免疫系统疾病等)、技术(聚合酶链式反应、等温核酸扩增技术) 、DNA 测序和下一代测序、DNA 微阵列、原位杂交等)、产品和服务(检测和试剂盒、仪器以及服务和软件)以及最终用户(医院和诊所、诊断实验室、研究和实验室)学术机构等)
No. of Pages: 167 | Report Code: TIPRE00026008 | Category: Life Sciences
No. of Pages: 167 | Report Code: TIPRE00026008 | Category: Life Sciences
分子诊断技术和平台正在应用于解剖和临床病理学的所有领域。与疾病相关的 DNA 或 RNA 序列,包括单核苷酸多态性、缺失、重排和插入,可以在分子诊断测试中检测到。 COVID-19出现后,分子诊断得到了进一步的改进。传统上,CT扫描、血液学检测和RT-PCR用于检测。随着 2020 年 COVID-19 病例的快速增长,对快速、精确的检测平台的需求激增,以克服传统检测的缺点。计算机断层扫描 (CT) 是一种成本密集型检查,可能并非所有医院都能提供,无法检测无症状患者的病毒感染和其他疾病。广泛使用的RT-PCR也耗时且昂贵,并且无法检测感染早期的低病毒载量。因此,研究人员开发了检测 SARS-CoV-2 的新方法,这种方法更快、更具成本效益。逆转录环介导等温扩增 (RT-LAMP)、基于微阵列的检测、基于适体的诊断、SHERLOCK、SHERLOCKv2、FET 生物传感器、基于细胞的电位诊断和分子印迹技术是新型分子诊断的一些例子为 COVID-19 诊断开发的技术。在过去几年中,FDA 报告表明分子检测、抗原依赖性检测和血清学检测方面的进步已得到批准。不同国家的科学界为管理 COVID-19 大流行和降低死亡率而共同努力,使整个分子工具和诊断领域受益,这可能会在未来为分子诊断市场创造重大机遇。
亚太地区包括马来西亚、泰国、印度、新加坡、菲律宾、越南、印度尼西亚、中国、日本、澳大利亚、韩国,以及亚太地区其他地区。老年人口的增加、癌症病例的增加、技术的进步以及初创公司、生物技术和生物制药公司数量的增加正在推动该地区的分子诊断市场。此外,该地区研究活动的增加以及提高癌症护理质量的协会或组织的存在有助于分子诊断市场的增长。
亚太地区分子诊断市场收入和到 2030 年的预测(百万美元)
亚太地区分子诊断市场细分为疾病领域、技术、产品和服务,最终
根据疾病领域,亚太分子诊断市场分为传染病、肿瘤、基因检测、心脏病、免疫系统疾病等。 2022年,传染病细分市场占据亚太分子诊断市场份额最大。
根据技术,亚太分子诊断市场细分为聚合酶链反应(PCR)、原位杂交、等温核酸扩增技术 (INAAT)、DNA 测序和下一代测序 (NGS)、DNA 微阵列等。聚合酶链反应 (PCR) 细分市场在 2022 年占据亚太地区最大的分子诊断市场份额。聚合酶链反应 (PCR) 进一步细分为 RT-PCR、qPCR、多重 PCR 等。
根据产品和服务,亚太分子诊断市场分为检测和试剂盒、仪器、服务和软件。 2022 年,检测和试剂盒领域占据亚太地区最大的分子诊断市场份额。
根据最终用户,亚太地区分子诊断市场分为诊断实验室、医院和诊所、研究和学术机构、和别的。 2022年,诊断实验室领域占据亚太地区最大的分子诊断市场份额。
按国家划分,亚太地区分子诊断市场分为印度、新加坡、马来西亚、菲律宾、泰国、印度尼西亚、越南、中国、日本、澳大利亚、韩国和亚太其他地区。 2022年,中国在亚太分子诊断市场占据主导地位。
雅培实验室、安捷伦科技公司、赛默飞世尔科技公司、罗氏公司、Qiagen NV、生物梅里埃公司、Illumina公司、丹纳赫、Siemens Healthineers AG、Novartis AG 和 TBG Diagnostics Limited 是亚太分子诊断市场上的一些领先公司。
Strategic insights for Asia Pacific Molecular Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 3,478.48 Million |
Market Size by 2030 | US$ 9,698.11 Million |
Global CAGR (2022 - 2030) | 13.7% |
Historical Data | 2020-2021 |
Forecast period | 2023-2030 |
Segments Covered |
By 疾病领域
|
Regions and Countries Covered | 亚太地区
|
Market leaders and key company profiles |
The regional scope of Asia Pacific Molecular Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Molecular Diagnostics Market is valued at US$ 3,478.48 Million in 2022, it is projected to reach US$ 9,698.11 Million by 2030.
As per our report Asia Pacific Molecular Diagnostics Market, the market size is valued at US$ 3,478.48 Million in 2022, projecting it to reach US$ 9,698.11 Million by 2030. This translates to a CAGR of approximately 13.7% during the forecast period.
The Asia Pacific Molecular Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Molecular Diagnostics Market report:
The Asia Pacific Molecular Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Molecular Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Molecular Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.